Saturday, Sun Pharma Advance Research Company the pharma research and drug discovery arm of Sun Pharma, reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.
The company had run up a net loss of Rs 9.40 crore for the same period a year ago, SPARC said in a filing to BSE. Stand-alone total income from operations stood at Rs 41.2 crore for the quarter under consideration.
It was Rs 42.70 crore for the year-ago period. For the fiscal year ended March, the net loss stood at Rs 69.9 crore. It was Rs 39.5 crore for the same period a year earlier.
Disclaimer :
The views, opinions, positions or strategies expressed by the authors and those providing comments are theirs alone, and do not necessarily reflect the views, opinions, positions or strategies of NTIPL,
english.newstracklive.com or any employee thereof. NTIPL makes no representations as to accuracy, completeness, correctness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use.
NTIPL reserves the right to delete, edit, or alter in any manner it sees fit comments that it, in its sole discretion, deems to be obscene, offensive, defamatory, threatening, in violation of trademark, copyright or other laws, or is otherwise unacceptable.
